When physical pain occurs—whether from an injury, surgery, or the ravages of cancer—finding the right product to alleviate symptoms can be a matter of trial and error, and is often fraught with side effects including addiction and overdose. WEX Pharmaceuticals Inc., a late-stage drug development company based in Vancouver, BC, is dedicated to reducing those threats through research, development, and manufacture of Halneuron®, a new non-opioid analgesic considered to be a breakthrough in pain-management technology.
